Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Amends Executive Consulting Agreements, Setting Annual Fees at $660,000

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$3.8
Mkt Cap
$1.906M
52W Low
$3.38
52W High
$686.28
Market data snapshot near publication time

Summary

PMGC Holdings Inc. has amended consulting agreements for its CEO/CFO/Director and Non-Executive Chairman, establishing combined annual fees of $660,000, effective January 1, 2026.


Key Events

  • CEO/CFO/Director Compensation Set

    The annual consulting fee for Graydon Bensler, serving as CEO, CFO, and Director via GB Capital Ltd, has been set at $300,000.

  • Chairman Compensation Set

    The annual consulting fee for Braeden Lichti, serving as Non-Executive Chairman via Northstrive Companies Inc., has been set at $360,000.

  • Agreements Effective January 1, 2026

    Both amended consulting agreements are effective as of January 1, 2026, establishing these annual fees for the current fiscal year.

  • Fifth Amendment to Existing Agreements

    These are the fifth amendments to consulting agreements originally established on October 25, 2024, indicating ongoing adjustments to executive compensation.


Analysis

For a company with a market capitalization of approximately $1.9 million, annual executive consulting fees totaling $660,000 represent a substantial fixed cost. This level of compensation is a very significant portion of the company's current valuation, raising significant concerns about cash burn and the allocation of resources, potentially impacting the company's financial runway and investor confidence.

At the time of this filing, ELAB was trading at $3.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $3.38 to $686.28. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Jun 08, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.56
Real-time Price: $1.55 info
Change: -$0.010 (-0.64%) info
Market Cap: $7.088M info
ELAB
Jun 08, 2026, 7:31 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.79
Real-time Price: $1.55 info
Change: -$0.240 (-13%) info
Market Cap: $7.088M info
ELAB
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $1.55 info
Change: +$0.030 (+2%) info
Market Cap: $7.088M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.55 info
Change: -$0.260 (-14%) info
Market Cap: $7.088M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.55 info
Change: -$0.260 (-14%) info
Market Cap: $7.088M info
ELAB
Jun 01, 2026, 7:35 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $1.55 info
Change: -$0.340 (-18%) info
Market Cap: $7.088M info
ELAB
May 15, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.01
Real-time Price: $1.55 info
Change: -$0.460 (-23%) info
Market Cap: $7.088M info
ELAB
May 14, 2026, 7:44 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $2.01
Real-time Price: $1.55 info
Change: -$0.460 (-23%) info
Market Cap: $7.088M info
ELAB
May 14, 2026, 6:52 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.01
Real-time Price: $1.55 info
Change: -$0.460 (-23%) info
Market Cap: $7.088M info
ELAB
May 13, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.98
Real-time Price: $1.55 info
Change: -$0.430 (-22%) info
Market Cap: $7.088M info